• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print


Legal & General Ucits Etf Public Limited Company L&G PHARMA BREAKTHROUGH GO UCITS ETF

Sell: $14.674|Buy: $14.724|Change: 0.10 (-0.70%)
Asset allocation %

Morningstar style box TM
Equity style
SizeLarge
Mid
Small
Value
Blend
Growth
Style

Size

Share class size (mil)18 GBP (19/11/2026)
Fund size (mil)18 GBP (19/11/2026)

Top 10 holdings

Assets in top 10 holdings %33.02
Total number of equity holdings40
Total number of bond holdings0
Holdings 18/11/2026% of assets
Xeris Biopharma Holdings Inc5.22
Genmab AS3.99
Xencor Inc3.39
United Therapeutics Corp3.10
Biogen Inc2.98
BeOne Medicines Ltd ADR2.95
AstraZeneca PLC2.90
Eisai Co Ltd2.87
Royalty Pharma PLC Class A2.81
Basilea Pharmaceutica Ltd Registered Shares2.81